Market revenue in 2023 | USD 6,516.2 million |
Market revenue in 2030 | USD 10,385.2 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Ceramics & bioactive glass biomaterials |
Fastest growing segment | Polymers Biomaterials |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ceramics & Bioactive Glass Biomaterials, Polymers Biomaterials, Calcium Phosphate Cements, Metal Biomaterials, Composites |
Key market players worldwide | Koninklijke DSM NV, Evonik Industries AG, Stryker Corp, DePuy Synthes, Zimmer Biomet Holdings Inc, Globus Medical Inc Class A, Exactech, Matexcel, AdvanSource Biomaterials Corporation, Invibio, CAM Bioceramics, Heraeus |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.
Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.67% in 2023. Horizon Databook has segmented the U.S. orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.
According to the estimates provided by American Academy of Orthopedic Surgeons in 2019, about 700,000 total knee replacement surgeries and 400,000 total hip replacement surgeries were performed in the U.S. As the number of replacement surgeries are increasing, the demand for orthopedic implants is also increasing.
This is further anticipated to drive the market for orthopedic biomaterials. Furthermore, growing prevalence of osteoporosis and osteoarthritis and increasing geriatric population are expected to drive the market over the forecast period.
According to the estimates provided by the National Osteoporosis Foundation (NOF) in 2014, the U.S. has around 54 million people aged 50 and above affected by osteoporosis, arthritis, and various other low bone mass conditions.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. orthopedic biomaterials market, including forecasts for subscribers. This country databook contains high-level insights into U.S. orthopedic biomaterials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account